Hierarchical clustering of the correlation matrix suggests that the expression of three PP2A inhibitors, ARPP19, PME1 and SET, form a cluster with similar expression patterns across AML patient samples (Figure 1i). The gene discussed is PTPA; the disease is acute myeloid leukemia.